1. robflutie
2. ggordon100
3. rdjr2
4. 007Bondsman
1.ggordon100 01/19/2018
Juno Therapeutics Inc May Be the Ideal Takeout Target for a Large Pharma like Celgene
2.robflutie 10/23/2017
Here is what is expected {Link}
3.rdjr2 01/24/2018
BMO Capital reiterates Buy rating, $144 PT
4.robflutie 01/08/2018
$CELG. news.
5.007Bondsman 01/22/2018
im ready
6.rdjr2 01/22/2018
Boom, buying Juno
7.rdjr2 10/23/2017
They have a lot in the pipeline, so Friday was a blip
8.rdjr2 01/23/2018
Surprised at the Neutral Rating Reiterate
9.007Bondsman 02/18/2018
OTEZLA® (Apremilast) Phase II Data Showed Clinically Meaningful Improvements in Patients with Active Ulcerative Colitis
10.ggordon100 01/22/2018
Should add a lot
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW